News about Hipra

Clínic-IDIBAPS, a key role in developing the Hipra vaccine

The HIPRA vaccine against COVID-19 is the first vaccine authorised for human health that has been designed and developed in Spain, and various servic1

Clínic Barcelona

Research November 15 2021

AEMPS authorizes Phase IIb clinical trial of HIPRA Covid-19 vaccine

The biotechnological pharmaceutical company HIPRA has received authorization from the Spanish Agencyfor Medicines and Health Products (AEMPS) to sta1

Clínic Barcelona

Research August 27 2021

The clinical trial of the HIPRA vaccine against COVID-19 is progressing with the administration of the first doses to humans

This week the vaccine began to be administered to the first volunteers participating in Phase I/IIa of the trial at the Hospital Trueta in Girona and1

Clínic Barcelona

Research July 14 2021

Are you between 18 and 39 years old and do you want to take part in a PHASE I trial of a new COVID-19 vaccine?

HIPRA (Amer, Girona) is looking for volunteers aged between 18 and 39 who have not received any COVID-19 vaccine and who have not had the infection,1

News about Hipra

Clínic-IDIBAPS, a key role in developing the Hipra vaccine

AEMPS authorizes Phase IIb clinical trial of HIPRA Covid-19 vaccine

The clinical trial of the HIPRA vaccine against COVID-19 is progressing with the administration of the first doses to humans

Are you between 18 and 39 years old and do you want to take part in a PHASE I trial of a new COVID-19 vaccine?

Subscribe to the Newsletter of Clínic